Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in KCNC1-related Disorder
NCT06341127Completed
- Sponsor
- Holland Bloorview Kids Rehabilitation Hospital
- Start
- Jan 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of fluoxetine in KCNC1-related disorder, sponsored by Holland Bloorview Kids Rehabilitation Hospital. Primary endpoints: Motor development and Incidence of Treatment-Emergent Adverse Events. Started Jan 2024; status: completed.
02
Drugs
fluoxetine
03
Conditions
KCNC1-related disorder
Beyond the preview
Go deeper on NCT06341127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06341127.